Helping Children Receive an Earlier Autism Diagnosis
Earlier Diagnosis + Earlier Intervention = Better Outcomes

Our blood test is validated by our National Institutes of Mental Health clinical study, the largest study to evaluate the metabolism of children with autism.

The results of our clinical study were published in the scientific journal, Biological Psychiatry.

We improve the lives of children and families living with autism spectrum disorder by providing tools for earlier diagnosis and more precise treatment.


Talk to your healthcare Provider (pediatrician, family doctor) about requesting our test for your child.

Print the NeuroPointDX brochure which summarizes our company and our autism test for your Provider.

Sign-up to receive updates on our progress developing tools for autism diagnosis and treatment.
Posters and Publications
NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.
NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.